Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach

Giuseppe Mancia, Guido Grassi

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

When associated with high blood pressure, type 2 diabetes mellitus is characterised by a high risk of adverse cardiovascular (CV) and renal outcomes. However, both can be effectively reduced by antihypertensive treatment. Current guidelines on the treatment of hypertension emphasize the need to effectively treat high blood pressure in diabetic individuals, but their recommendations differ in terms of the optimal target blood pressure value to aim for in order to maximise CV and renal protection. In some guidelines the recommended target blood pressure values are <140/90 mmHg (systolic/diastolic), whereas in others, blood pressure values close or even less than 130/80 mmHg are recommended. This paper will discuss the evidence for and against a conservative or more aggressive blood pressure target for treated diabetic hypertensive individuals based on the evidence provided by randomised trials, trial meta-analyses and large observational studies. Based on the available evidence, it appears that blood pressure targets will probably have to be lower than <140/90 mmHg, and that values approaching 130/80 mmHg should be recommended. However, evidence in favour of even lower systolic values, i.e. <130 mmHg, is limited and is definitively against a reduction to <120 mmHg.

Original languageEnglish
Pages (from-to)517-525
Number of pages9
JournalDiabetologia
Volume61
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Type 2 Diabetes Mellitus
Blood Pressure
Hypertension
Guidelines
Kidney
Antihypertensive Agents
Observational Studies
Meta-Analysis

Keywords

  • Antihypertensive treatment
  • Blood pressure targets
  • Cardiovascular events
  • Cardiovascular morbidity
  • Cardiovascular mortality
  • Diabetes mellitus
  • Review

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach. / Mancia, Giuseppe; Grassi, Guido.

In: Diabetologia, Vol. 61, No. 3, 01.03.2018, p. 517-525.

Research output: Contribution to journalReview article

@article{55bc0e710a4848f19311515fd3a6b61a,
title = "Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach",
abstract = "When associated with high blood pressure, type 2 diabetes mellitus is characterised by a high risk of adverse cardiovascular (CV) and renal outcomes. However, both can be effectively reduced by antihypertensive treatment. Current guidelines on the treatment of hypertension emphasize the need to effectively treat high blood pressure in diabetic individuals, but their recommendations differ in terms of the optimal target blood pressure value to aim for in order to maximise CV and renal protection. In some guidelines the recommended target blood pressure values are <140/90 mmHg (systolic/diastolic), whereas in others, blood pressure values close or even less than 130/80 mmHg are recommended. This paper will discuss the evidence for and against a conservative or more aggressive blood pressure target for treated diabetic hypertensive individuals based on the evidence provided by randomised trials, trial meta-analyses and large observational studies. Based on the available evidence, it appears that blood pressure targets will probably have to be lower than <140/90 mmHg, and that values approaching 130/80 mmHg should be recommended. However, evidence in favour of even lower systolic values, i.e. <130 mmHg, is limited and is definitively against a reduction to <120 mmHg.",
keywords = "Antihypertensive treatment, Blood pressure targets, Cardiovascular events, Cardiovascular morbidity, Cardiovascular mortality, Diabetes mellitus, Review",
author = "Giuseppe Mancia and Guido Grassi",
year = "2018",
month = "3",
day = "1",
doi = "10.1007/s00125-017-4537-3",
language = "English",
volume = "61",
pages = "517--525",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach

AU - Mancia, Giuseppe

AU - Grassi, Guido

PY - 2018/3/1

Y1 - 2018/3/1

N2 - When associated with high blood pressure, type 2 diabetes mellitus is characterised by a high risk of adverse cardiovascular (CV) and renal outcomes. However, both can be effectively reduced by antihypertensive treatment. Current guidelines on the treatment of hypertension emphasize the need to effectively treat high blood pressure in diabetic individuals, but their recommendations differ in terms of the optimal target blood pressure value to aim for in order to maximise CV and renal protection. In some guidelines the recommended target blood pressure values are <140/90 mmHg (systolic/diastolic), whereas in others, blood pressure values close or even less than 130/80 mmHg are recommended. This paper will discuss the evidence for and against a conservative or more aggressive blood pressure target for treated diabetic hypertensive individuals based on the evidence provided by randomised trials, trial meta-analyses and large observational studies. Based on the available evidence, it appears that blood pressure targets will probably have to be lower than <140/90 mmHg, and that values approaching 130/80 mmHg should be recommended. However, evidence in favour of even lower systolic values, i.e. <130 mmHg, is limited and is definitively against a reduction to <120 mmHg.

AB - When associated with high blood pressure, type 2 diabetes mellitus is characterised by a high risk of adverse cardiovascular (CV) and renal outcomes. However, both can be effectively reduced by antihypertensive treatment. Current guidelines on the treatment of hypertension emphasize the need to effectively treat high blood pressure in diabetic individuals, but their recommendations differ in terms of the optimal target blood pressure value to aim for in order to maximise CV and renal protection. In some guidelines the recommended target blood pressure values are <140/90 mmHg (systolic/diastolic), whereas in others, blood pressure values close or even less than 130/80 mmHg are recommended. This paper will discuss the evidence for and against a conservative or more aggressive blood pressure target for treated diabetic hypertensive individuals based on the evidence provided by randomised trials, trial meta-analyses and large observational studies. Based on the available evidence, it appears that blood pressure targets will probably have to be lower than <140/90 mmHg, and that values approaching 130/80 mmHg should be recommended. However, evidence in favour of even lower systolic values, i.e. <130 mmHg, is limited and is definitively against a reduction to <120 mmHg.

KW - Antihypertensive treatment

KW - Blood pressure targets

KW - Cardiovascular events

KW - Cardiovascular morbidity

KW - Cardiovascular mortality

KW - Diabetes mellitus

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=85040936889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040936889&partnerID=8YFLogxK

U2 - 10.1007/s00125-017-4537-3

DO - 10.1007/s00125-017-4537-3

M3 - Review article

C2 - 29372279

AN - SCOPUS:85040936889

VL - 61

SP - 517

EP - 525

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 3

ER -